First fair-price pharmacy to open its doors in Gurugram today

GURUGRAM: Medicines and diagnostic tests will be available in the city at a lower prices than current ones.

The MCG, along with the health department and a pharma company, will on Saturday launch Haryana’s first such fair-price pharmacy — Affordable Medicines and Reliable Implants for Treatment (Amrit) — in Gurugram, where medicines, particularly for cancer and cardiovascular diseases, will be available at prices three times less than the market rate.

Union health minister JP Nadda will inaugurate the Amrit pharmacy at Mahaveer Chowk near the Gurugram bus stand and the diagnostic laboratory in Sector 39, officials said on Friday. This is part of the Union government’s plan to open 300 such pharmacies across the country.

“All medicines at the pharmacy will be sold at subsidised rates, upto 60% of the MRP,” said an MCG official. “Anyone with a prescription will be able to make purchase at the pharmacy. And though it will stock drugs for all diseases, it would especially focus on easy availability of medicines for cancer and cardiovascular diseases,” he added.

Though the diagnostic laboratory will be inaugurated on Saturday, it will be operational from April. “All kinds of diagnostic test facilities will be available at the centre. The rates for the lab will be the same as applicable under the Central Government Health Scheme,” said the official.

The first Amrit pharmacy was opened at AIIMS in Delhi in 2015. The project was launched by the Centre in association with state-owned HLL Lifecare limited. However, in many places, these pharmacies were reported to be inefficient in handling the demands. And given Gurugram’s size, many say, it might prove to be the same case here as well.

  • Related Posts

    Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

    Fujifilm India, a leading healthcare technology company, has expanded its ELUXEO 8000 endoscopy portfolio with the launch of its next-generation therapeutic gastroscopes at Endocon 2026. India is witnessing a growing…

    Draft bill proposes powers for DIs to inspect online pharmacy office premises

    Amidst years of uncertainty over the regulation of e-pharmacies in the country, the draft Drugs, Medical Devices and Cosmetics Bill, 2026, proposes to bestow the powers with the drugs inspectors…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

    Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

    Draft bill proposes powers for DIs to inspect online pharmacy office premises

    Draft bill proposes powers for DIs to inspect online pharmacy office premises

    Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

    Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

    FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

    FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

    Delhi DCA mandates digital tracking for controlled substances on new DMS portal

    Delhi DCA mandates digital tracking for controlled substances on new DMS portal

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?